Logo

American Heart Association

  13
  0


Final ID: Mo3060

Coronary Calcium Density Parameters Improve Cardiovascular Risk Prediction beyond Agatston Score in Adults Aged 75 and Older: The Atherosclerosis Risk in Communities (ARIC) Study

Abstract Body (Do not enter title and authors here): Background: Coronary artery calcium (CAC) is usually quantified by Agatston score, integrating both density and plaque area. Recently, calcium density is shown to be inversely associated with cardiovascular disease (CVD) at a given CAC volume predominantly among middle-aged adults. However, its prognostic value has not been specifically assessed in adults aged ≥75 years. Also, most previous studies investigated average CAC density (total Agatston score divided by total CAC volume) whereas CAC density could be parameterized in various ways (e.g., the highest density across all plaques or average of the highest density across every plaque).

Aim: To explore whether CAC density parameters can improve CVD risk prediction beyond Agatston score in the 75-and-older population.

Methods: We analyzed 1,455 ARIC study participants (mean age 80.4 [SD 4.2] years, 58.2% female, 18.2% Black) with a CAC Agatston score >0 at visit 7 (2018–2019). We used elastic net regression to identify predictive density parameters out of 20 density parameters based on Hounsfield unit distribution of each calcified plaque across multiple plaques, if any, in every participant). Then, we evaluated improvement in risk prediction of CVD (coronary heart disease, stroke, heart failure) using Harrell's C-statistic and net reclassification improvement (NRI) based on Cox models.

Results: Elastic net regression including log-transformed CAC volume selected 5 CAC density metrics (mean of density standard deviation, median of minimum density, maximum of minimum density, maximum of maximum density, minimum of maximum density across calcified plaques). Adding these 5 density parameters to traditional risk factors improved CVD risk prediction (ΔC-statistic 0.060 [95%CI 0.032, 0.093]) more than when we added Agatston score (0.046 [0.012, 0.093]) (top half of Table). These 5 CAC density parameters improved risk prediction even when Agatston score was included in the base model (the bottom row of Table). This result was similar for NRI.

Conclusions: In the 75-and-older population, selected CAC density parameters significantly improved CVD risk prediction beyond and above Agatston score. Our findings underscore the potential of improving how to interpret and utilize CAC for clinical management in older populations.
  • Liu, Hairong  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Mok, Yejin  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Shah, Amil  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Chen, Lin Yee  ( UNIVERSITY OF MINNESOTA , Minneapolis , Minnesota , United States )
  • Budoff, Matthew  ( LUNDQUIST INSTITUTE , Torrance , California , United States )
  • Blaha, Michael  ( JOHNS HOPKINS HOSPITAL , Baltimore , Maryland , United States )
  • Matsushita, Kunihiro  ( JOHNS HOPKINS UNIVERSITY , Baltimore , Maryland , United States )
  • Author Disclosures:
    Hairong Liu: DO NOT have relevant financial relationships | Yejin Mok: DO NOT have relevant financial relationships | Amil Shah: DO NOT have relevant financial relationships | Lin Yee Chen: DO NOT have relevant financial relationships | Matthew Budoff: DO have relevant financial relationships ; Researcher:Lilly:Active (exists now) ; Speaker:Boehringer-Ingleheim:Active (exists now) ; Speaker:Lilly:Active (exists now) ; Speaker:Novo Nordisk:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Researcher:Amgen:Active (exists now) | Michael Blaha: DO have relevant financial relationships ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Consultant:Eli Lilly:Past (completed) ; Consultant:Boehringer Ingelheim:Past (completed) ; Consultant:Astra Zeneca:Past (completed) ; Consultant:New Amsterdam:Active (exists now) ; Consultant:Agepha:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Idorsia:Past (completed) ; Consultant:Genentech:Past (completed) ; Consultant:Bayer:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Research Funding (PI or named investigator):Bayer:Active (exists now) | Kunihiro Matsushita: DO have relevant financial relationships ; Consultant:RhythmX AI:Past (completed) ; Other (please indicate in the box next to the company name):Fukuda Denshi:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Novel Biomarkers, Indices & Blood-Pressure Targets in Stable CAD

Monday, 11/10/2025 , 01:00PM - 02:00PM

Abstract Poster Board Session

More abstracts on this topic:
Association of the Alternative Healthy Eating Index with Coronary Artery Calcification Volume and Density: the Multi-Ethnic Study of Atherosclerosis

Cannon Ethan, Mcclelland Robyn, Wood Alexis, Budoff Matthew, Allison Matthew, Criqui Michael, Jacobs David, Lutsey Pamela

9p21.3 variants drive coronary calcification by suppressing statherin expression

Soheili Fariborz, Almontashiri Naif, Heydarikhorneh Niloufar, Vilmundarson Ragnar, Chen Hsiao-huei, Stewart Alexandre

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available